TGFBI anticorps

N° du produit ABIN7245623

Détail du produit anti-TGFBI anticorps

Antigène: TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TGFBI est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Attributs du produit: Polyclonal Antibody

Purification: Antigen affinity purification

Immunogène: Fusion protein of human TGFBI

Isotype: IgG

Information d'application

Indications d'application: WB 1:500-1:2000, IHC 1:50-1:200, ELISA 1:5000-1:10000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.02 mg/mL

Buffer: PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur TGFBI

Antigène: TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))

Autre désignation: TGFBI (TGFBI Produits)

Synonymes: anticorps TGFBI, anticorps BIGH3, anticorps CDB1, anticorps CDG2, anticorps CDGG1, anticorps CSD, anticorps CSD1, anticorps CSD2, anticorps CSD3, anticorps EBMD, anticorps LCD1, anticorps 68kDa, anticorps AI181842, anticorps AI747162, anticorps Beta-ig, anticorps big-h3, anticorps Big-h3, anticorps MP70, anticorps MP78, anticorps hm:zeh0933, anticorps wu:fa13f05, anticorps zgc:110495, anticorps transforming growth factor beta induced, anticorps transforming growth factor, beta induced, anticorps transforming growth factor, beta-induced, anticorps TGFBI, anticorps Tgfbi, anticorps tgfbi

Sujet: TGFBI,also named as BIGH3,Kerato-epithelin and RGD-CAP,binds to type I,II,and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage,it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein,it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy,and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy. Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).

Poids moléculaire:

Observed_MW: Refer to figures

Calculated_MW: 75 kDa

UniProt: Q15582